1921
Volume 93, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Previous population-based studies have examined treatment impact on -associated urinary tract disease among children, but much less is known about longer-term treatment benefits for affected adult populations in areas where risk of recurrent infection is high. In communities in Msambweni, along the Kenya coast, we identified, using a portable ultrasound, 77 adults (aged 17–85) with moderate-to-severe obstructive uropathy or bladder disease due to . Treatment response was assessed by repeat ultrasound 1–2 years after praziquantel (PZQ) therapy and compared with interval changes among age- and sex-matched infected/treated control subjects who did not have urinary tract abnormalities at the time of initial examination. Of the 77 affected adults, 62 (81%) had improvement in bladder and/or kidney scores after treatment, 14 (18%) had no change, and one (1.3%) had progression of disease. Of the 77 controls, 75 (97%) remained disease free by ultrasound, while two (3%) had apparent progression with abnormal findings on follow-up examination. We conclude that PZQ therapy for is effective in significantly reducing urinary tract morbidity from urogenital schistosomiasis among adult age groups, and affected adults stand to benefit from inclusion in mass treatment campaigns.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.15-0153
2015-08-05
2019-12-05
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/2/371.html?itemId=/content/journals/10.4269/ajtmh.15-0153&mimeType=html&fmt=ahah

References

  1. Engels D, Chitsulo L, Montresor A, Savioli L, , 2002. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop 82: 139146.[Crossref] [Google Scholar]
  2. Schur N, Hurlimann E, Garba A, Traore MS, Ndir O, Ratard RC, Tchuem Tchuente LA, Kristensen TK, Utzinger J, Vounatsou P, , 2011. Geostatistical model-based estimates of schistosomiasis prevalence among individuals aged ≤ 20 years in west Africa. PLoS Negl Trop Dis 5: e1194.[Crossref] [Google Scholar]
  3. Schur N, Hurlimann E, Stensgaard AS, Chimfwembe K, Mushinge G, Simoonga C, Kabatereine NB, Kristensen TK, Utzinger J, Vounatsou P, , 2013. Spatially explicit Schistosoma infection risk in eastern Africa using Bayesian geostatistical modelling. Acta Trop 128: 365377.[Crossref] [Google Scholar]
  4. Mutapi F, , 2011. Improving diagnosis of urogenital schistosome infection. Expert Rev Anti Infect Ther 9: 863865.[Crossref] [Google Scholar]
  5. Hueper WC, , 1969. Occupational and Environmental Cancers of the Urinary System. New Haven, CT: Yale University Press. [Google Scholar]
  6. Makar N, , 1955. Urological Aspects of Bilharziasis in Egypt. Cairo, Egypt: Société Orientale de Publicité. [Google Scholar]
  7. Chen MG, Mott KE, , 1989. Progress in assessment of morbidity due to Schistosoma haematobium infection. Trop Dis Bull 86: R1R36. [Google Scholar]
  8. Sayegh ES, Dimmette RM, , 1956. The fibrotic contracted urinary bladder associated with schistosomiasis and chronic ulceration: a clinicopathological study including treatment. J Urol 75: 671679. [Google Scholar]
  9. Forsyth DM, Bradley DJ, McMahon J, , 1970. Death attributed to kidney failure in communities with endemic urinary schistosomiasis. Lancet 2: 472473.[Crossref] [Google Scholar]
  10. WHO, 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. Geneva, Switzerland: World Health Organization. [Google Scholar]
  11. WHO, 2006. Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers. Geneva, Switzerland: World Health Organization. [Google Scholar]
  12. Hatz C, Mayombana C, de Savigny D, MacPherson CNL, Koella JC, Degremont A, , 1990. Ultrasound scanning for detecting morbidity due to Schistosoma haematobium and its resolution following treatment with different doses of praziquantel. Trans R Soc Trop Med Hyg 84: 8488.[Crossref] [Google Scholar]
  13. Houston S, , 1991. Ultrasound: appropriate technology for tropical field work. Trans R Soc Trop Med Hyg 85: 321323.[Crossref] [Google Scholar]
  14. Abdel-Wahab MF, Ramzy I, Esmat G, el Kafass H, Strickland GT, , 1992. Ultrasound for detecting Schistosoma haematobium urinary tract complications: comparison with radiographic procedures. J Urol 148: 346350. [Google Scholar]
  15. Doehring-Schwerdtfeger E, Kaiser C, Schlake J, Abdel-Rahim IM, Mohamed-Ali Q, Richter J, Franke D, Kardorff R, Elsheikh M, Ehrich JH, , 1992. Ultrasound versus clinical examination as indication for Schistosoma mansoni associated morbidity in children. Trop Med Parasitol 43: 245248. [Google Scholar]
  16. King CH, , 2002. Ultrasound monitoring of structural urinary tract disease in S. haematobium infection. Mem Inst Oswaldo Cruz 97 (Suppl 1): 149152.[Crossref] [Google Scholar]
  17. Richter J, Hatz C, Campagne G, Bergquist NR, Jenkins JM, , 2000. Ultrasound in Schistosomiasis: A Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-Related Morbidity. Geneva, Switzerland: World Health Organization. [Google Scholar]
  18. Clennon JA, King CH, Muchiri EM, Kariuki HC, Ouma JH, Mungai P, Kitron U, , 2004. Spatial patterns of urinary schistosomiasis infection in a highly endemic area of coastal Kenya. Am J Trop Med Hyg 70: 443448. [Google Scholar]
  19. King CH, Blanton RE, Muchiri EM, Ouma JH, Kariuki HC, Mungai P, Magak P, Kadzo H, Ireri E, Koech D, , 2004. Low heritable component of risk for infection intensity and infection-associated disease in urinary schistosomiasis among Wadigo village populations in Coast Province, Kenya. Am J Trop Med Hyg 70: 5762. [Google Scholar]
  20. Peters PAS, Mahmoud AAF, Warren KS, Ouma JH, Siongok TKA, , 1976. Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull World Health Organ 54: 159162. [Google Scholar]
  21. King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, Kinyanjui H, Ouma J, Odiambo O, Bryan PJ, Muruka J, Magak P, Weinert D, Mackay W, Ransohoff D, Houser H, Koech D, Siongok TK, Mahmoud AAF, , 1988. Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg 39: 295305. [Google Scholar]
  22. King CH, Muchiri EM, Mungai P, Ouma JH, Kadzo H, Magak P, Koech D, , 2002. Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haematobium infection. Am J Trop Med Hyg 66: 725730. [Google Scholar]
  23. Magak P, King CH, Ireri E, Kadzo H, Ouma JH, Muchiri EM, , 2004. High prevalence of ectopic kidney in Coast Province, Kenya. Trop Med Int Health 9: 595600.[Crossref] [Google Scholar]
  24. Lucas AO, Adeniyi-Jones CC, Cockshott WP, Gilles HM, , 1966. Radiological changes after medical treatment of vesical schistosomiasis. Lancet 1: 631633.[Crossref] [Google Scholar]
  25. Davis A, , 1966. Radiological changes after treatment of vesical schistosomiasis [letter]. Lancet ii: 546.[Crossref] [Google Scholar]
  26. Farid Z, Bassily S, McConnell E, Schulert A, Sabour M, Abdel Wahab MF, , 1967. Symptomatic, radiological, and functional improvement following treatment of urinary schistosomiasis in Egypt. Lancet 2: 11101113.[Crossref] [Google Scholar]
  27. Macdonald G, Forsyth DM, Rashid C, , 1968. Urological complications of endemic schistosomiasis in schoolchildren. 4. As modified by treatment. Trans R Soc Trop Med Hyg 62: 775781.[Crossref] [Google Scholar]
  28. Pugh RN, Gilles HM, , 1979. Malumfashi Endemic Disease Research Project, VIII. Follow-up intravenous urograms of boys infected with Schistosoma haematobium from the Malumfashi area. Ann Trop Med Parasitol 73: 191192.[Crossref] [Google Scholar]
  29. Doehring E, Reider F, Schmidt-Ehry G, Ehrich JH, , 1985. Reduction of pathological findings in urine and bladder lesions in infection with Schistosoma haematobium after treatment with praziquantel. J Infect Dis 152: 807810.[Crossref] [Google Scholar]
  30. Doehring E, Ehrich JHH, Bremer HJ, , 1986. Reversibility of urinary tract abnormalities due to Schistosoma haematobium infection. Kidney Int 30: 582585.[Crossref] [Google Scholar]
  31. King CH, Muchiri EM, Ouma JH, , 1992. Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations. Mem Inst Oswaldo Cruz 87: 203210.[Crossref] [Google Scholar]
  32. Kardorff R, Traore M, Doehring-Schwerdtfeger E, Vester U, Ehrich JH, , 1994. Ultrasonography of ureteric abnormalities induced by Schistosoma haematobium infection before and after praziquantel treatment. Br J Urol 74: 703709.[Crossref] [Google Scholar]
  33. Medhat A, Zarzour A, Nafeh M, Shata T, Sweifie Y, Attia M, Helmy A, Shehata M, Zaki S, Mikhail N, Ibrahim S, King CL, Strickland GT, , 1997. Evaluation of an ultrasonographic score for urinary bladder morbidity in Schistosoma haematobium infection. Am J Trop Med Hyg 57: 1619. [Google Scholar]
  34. Delegue P, Picquet M, Shaw DJ, Vercruysse J, Sambou B, Ly A, , 1998. Morbidity induced by Schistosoma haematobium infections, as assessed by ultrasound before and after treatment with praziquantel, in a recently expanded focus (Senegal River basin). Ann Trop Med Parasitol 92: 775783.[Crossref] [Google Scholar]
  35. Hatz CF, Vennervald BJ, Nkulila T, Vounatsou P, Kombe Y, Mayombana C, Mshinda H, Tanner M, , 1998. Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. Am J Trop Med Hyg 59: 775781. [Google Scholar]
  36. Wagatsuma Y, Aryeetey ME, Sack DA, Morrow RH, Hatz C, Kojima S, , 1999. Resolution and resurgence of Schistosoma haematobium-induced pathology after community-based chemotherapy in Ghana, as detected by ultrasound. J Infect Dis 179: 15151522.[Crossref] [Google Scholar]
  37. Garba A, Campagne G, Tassie JM, Barkire A, Vera C, Sellin B, Chippaux JP, , 2004. Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger. Bull Soc Pathol Exot 97: 711. [Google Scholar]
  38. Ekwunife CA, Okafor FC, Nwaorgu OC, , 2009. Ultrasonographic screening of urinary schistosomiasis infected patients in Agulu community, Anambra state, southeast Nigeria. Int Arch Med 2: 34.[Crossref] [Google Scholar]
  39. King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, Kinyanjui H, Ouma J, Odiambo O, Bryan PJ, Muruka J, Magak P, Weinert D, Mackay W, Ransohoff D, Houser H, Koech D, Siongok TK, Mahmoud AAF, , 1990. Chemotherapy-based control of schistosomiasis haematobia. II. Metrifonate vs. praziquantel in control of infection-associated morbidity. Am J Trop Med Hyg 42: 587595. [Google Scholar]
  40. Smith JH, Christie JD, , 1986. The pathobiology of Schistosoma haematobium infection in humans. Hum Pathol 17: 333345.[Crossref] [Google Scholar]
  41. Bustinduy AL, Sutherland LJ, Chang-Cojulun A, Malhotra I, DuVall AS, Fairley JK, Mungai PL, Muchiri EM, Mutuku F, Kitron U, King CH, , 2015. Age-stratified profiles of serum IL-6, IL-10, and TNF-α cytokines among Kenyan children having Schistosoma haematobium, Plasmodium falciparum, and other chronic parasitic co-infections. Am J Trop Med Hyg (in press). [Google Scholar]
  42. Lehman JS, Jr Farid Z, Bassily S, , 1970. Mortality in urinary schistosomiasis. Lancet 2: 822823.[Crossref] [Google Scholar]
  43. Kjetland EF, Mduluza T, Ndhlovu PD, Gomo E, Gwanzura L, Midzi N, Mason PR, Friis H, Gundersen SG, , 2006. Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel. Trans R Soc Trop Med Hyg 100: 740752.[Crossref] [Google Scholar]
  44. Leutscher P, Ramarokoto CE, Reimert C, Feldmeier H, Esterre P, Vennervald BJ, , 2000. Community-based study of genital schistosomiasis in men from Madagascar [letter]. Lancet 355: 117118.[Crossref] [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0153
Loading
/content/journals/10.4269/ajtmh.15-0153
Loading

Data & Media loading...

  • Received : 24 Feb 2015
  • Accepted : 06 Apr 2015
  • Published online : 05 Aug 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error